Job Description:
The computational biology (CB) group within research is seeking a motivated and productive student intern to support our bioinformatics efforts using next generation sequencing data. The CB group collaborates with research and translational biology to develop and evaluate new drugs and targets to fight cancer. Responsibilities:
Additional Info:
Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status. Targeting Cancer. Transforming Therapies. Revolutionary science meets transformative cancer therapy Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients. ADCs are an integral part of the evolving cancer treatment paradigm with their specificity, stability and potency. In addition to one marketed product, we are advancing a strong product pipeline designed to address significant unmet medical needs.[Click Here to Access the Original Job Post]
The computational biology (CB) group within research is seeking a motivated and productive student intern to support our bioinformatics efforts using next generation sequencing data. The CB group collaborates with research and translational biology to develop and evaluate new drugs and targets to fight cancer. Responsibilities:
- Work closely with our CB and bioinformatics team to identify metrics and implement approaches to evaluate the quality and relationships within and between our sequencing data sets.
- Develop a process, database and front end GUI to curate and review our high throughput genomics data.
- Must be in the process of earning an undergraduate or graduate degree in computer science, biostatistics, genomics or related field.
- Advanced experience programming in R, RShiny and/or Python.
- Prior experience with bioinformatics, DNA or RNA sequencing data, and data mining a strong plus.
- Excellent organization with attention to documenting and explaining your work.
- A team player with good verbal and written communication skills.
Skills :
- Bioinformatics
- Data Mining
- DNA sequencing
- Next Generation Sequencing
- Programing in Python
- Programing Skills
- Programming in R
- RNA-seq
Areas :
Additional Info:
Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status. Targeting Cancer. Transforming Therapies. Revolutionary science meets transformative cancer therapy Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients. ADCs are an integral part of the evolving cancer treatment paradigm with their specificity, stability and potency. In addition to one marketed product, we are advancing a strong product pipeline designed to address significant unmet medical needs.[Click Here to Access the Original Job Post]